RCMI Coordinating Center (RCMI CC) Header Logo

Angabin Matin

Faculty RankResearch Scientist/Res. Assoc. Prof.
InstitutionTexas Southern University
DepartmentPharmaceutical Sciences
Address3100 Ceburne Street
Houston TX 77004
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA093754     (MATIN, ANGABIN)Jul 1, 2003 - Apr 30, 2010
    Testicular Cancer Susceptibility Genes on Mouse Chr 19.
    Role: Principal Investigator

    R21CA175833     (MATIN, ANGABIN)Sep 22, 2014 - Aug 31, 2018
    Use of DND1 to counteract miRNA function in cancers
    Role: Principal Investigator

    R21CA186033     (MATIN, ANGABIN)Dec 2, 2014 - Nov 30, 2018
    The genetics of SF1 (splicing factor 1) in cancers
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang Y, Li Y, Chachad D, Liu B, Godavarthi JD, Williams-Villalobo A, Lasisi L, Xiong S, Matin A. In silico analysis of DND1 and its co-expressed genes in human cancers. Biochem Biophys Rep. 2022 Mar; 29:101206. PMID: 35059511.
    2. Zhang Y, Godavarthi JD, Williams-Villalobo A, Polk S, Matin A. The Role of DND1 in Cancers. Cancers (Basel). 2021 Jul 22; 13(15). PMID: 34359581.
    3. Godavarthi JD, Polk S, Nunez L, Shivachar A, Glenn Griesinger NL, Matin A. Deficiency of Splicing Factor 1 (SF1) Reduces Intestinal Polyp Incidence in ApcMin/+ Mice. Biology (Basel). 2020 Nov 13; 9(11). PMID: 33202710.
    4. Nunez L, Mokkapati S, Yu C, Deng JM, Behringer RR, Matin A. Generation of a novel mouse strain with conditional, cell-type specific, expression of DND1. Genesis. 2019 11; 57(11-12):e23335. PMID: 31513344.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    5. Som A, Xiao L, Zhu R, Guo CC, Xiao L, Rao P, Efstathiou E, Matin A, Tu SM. Clinically atypical seminomas with yolk sac tumor features. Can J Urol. 2013 Aug; 20(4):6860-7. PMID: 23930614.
      Citations: 1     Fields:    Translation:Humans
    6. Ali S, Karki N, Bhattacharya C, Zhu R, MacDuff DA, Stenglein MD, Schumacher AJ, Demorest ZL, Harris RS, Matin A, Aggarwal S. APOBEC3 inhibits DEAD-END function to regulate microRNA activity. BMC Mol Biol. 2013 Jul 26; 14:16. PMID: 23890083.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    7. Zhu R, Iacovino M, Mahen E, Kyba M, Matin A. Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells. BMC Mol Biol. 2011 Aug 18; 12:37. PMID: 21851623.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    8. Som A, Zhu R, Guo CC, Efstathiou E, Xiao L, Pisters LL, Matin A, Tu SM. Recurrent seminomas: clinical features and biologic implications. Urol Oncol. 2012 Jul-Aug; 30(4):494-501. PMID: 20822932.
      Citations: 4     Fields:    Translation:Humans
    9. Zhu R, Heaney J, Nadeau JH, Ali S, Matin A. Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors. Cancer Res. 2010 Sep 15; 70(18):7264-72. PMID: 20736371.
      Citations: 16     Fields:    Translation:AnimalsCells
    10. Hammond SS, Matin A. Tools for the genetic analysis of germ cells. Genesis. 2009 Sep; 47(9):617-27. PMID: 19548313.
      Citations: 11     Fields:    Translation:AnimalsCells
    11. Bhattacharya C, Aggarwal S, Kumar M, Ali A, Matin A. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1). PLoS One. 2008 May 28; 3(5):e2315. PMID: 18509452.
      Citations: 14     Fields:    Translation:AnimalsCells
    12. Hammond S, Zhu R, Youngren KK, Lam J, Anderson P, Matin A. Chromosome X modulates incidence of testicular germ cell tumors in Ter mice. Mamm Genome. 2007 Dec; 18(12):832-8. PMID: 18049836.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    13. Zhu R, Bhattacharya C, Matin A. The role of dead-end in germ-cell tumor development. Ann N Y Acad Sci. 2007 Dec; 1120:181-6. PMID: 17905939.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    14. Zhu R, Ji Y, Xiao L, Matin A. Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain. Mamm Genome. 2007 Aug; 18(8):584-95. PMID: 17671812.
      Citations: 10     Fields:    Translation:AnimalsCells
    15. Bhattacharya C, Aggarwal S, Zhu R, Kumar M, Zhao M, Meistrich ML, Matin A. The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. Biochem Biophys Res Commun. 2007 Mar 30; 355(1):194-9. PMID: 17291453.
      Citations: 19     Fields:    Translation:AnimalsCells
    16. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B, Rubin EM, Nadeau JH, Matin A. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature. 2005 May 19; 435(7040):360-4. PMID: 15902260.
      Citations: 154     Fields:    Translation:AnimalsCells
    Matin's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (99)
    Co-Authors (1)
    Similar People (60)
    Same Department Expand Description
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support